Secondaries

• DPE Deutsche Private Equity continuation vehicle establishment
  Structuring and launching a €708 million continuation fund, enabling the firm to retain and grow key assets. Supported Germany’s largest GP-led secondary, helping DPE secure long-term value for investors.
• Bid Equity Continuation Fund I
  Establishing a $300 million continuation fund, supporting long-term value creation for portfolio companies everii and JustRelate.
• Greenpeak Continuation Fund I 
  €347 million continuation vehicle to maintain investment in Academia and Certania, two strongly performing lab and TIC groups started and built up by GREENPEAK's Fund II.
• Vaaka Partners on Tietokeskus continuation vehicle
  Structuring a €73 million Finnish continuation vehicle, enabling liquidity options and supporting the ongoing growth of a major IT services company.
• Capiton AG - Single asset continuation vehicle for KG-Pharma Group
  Structuring and executing a single asset continuation vehicle for KG-Pharma Group, enabling existing and new investors to participate alongside Pantheon and Abrdn, and supporting client objectives for liquidity and value creation.
• Capiton AG - GP-led continuation vehicle for TMT assets 
  Establishing a GP-led continuation vehicle for two high-performing TMT assets from capiton V, facilitating continued growth and investor alignment through a tailored secondary transaction.
• Ufenau Capital Partners
  Transferring two assets from its German Asset Light Fund to a continuation vehicle. Helped the client achieve liquidity and ongoing management of high-performing investments.
• Ufenau Capital Partners
  Advised on a second GP-led secondaries deal, selling three companies from its fifth and sixth funds to a €450 million continuation vehicle. Helped secure investor support despite challenging market conditions.
• Capvis AG continuation vehicle for portfolio companies 
  Creating a continuation vehicle for three portfolio companies, backed by leading secondary investors. Enabled Capvis to deliver liquidity and future growth for investors and management teams.

Kline Hill Partners

• Acorn Sentry Aerospares CV secondary acquisition
  $350 million secondary acquisition, enabling efficient portfolio management and supporting strategic growth in the aviation sector.
• PHI Continuation Fund I formation 
  Structuring and launching a €212 million continuation fund, enabling ongoing investment in high-performing assets.
• Phoenix PEP Growth Partnership L.P 
  Structuring a £260 million secondary deal, providing strategic legal guidance to optimise fund performance and investor returns.
• Investcorp Technology Partners Nexus
  $100 million secondary investment, enhancing access to innovative technology assets.
• Anchorage Co-Investment Fund V secondary transaction
  $250 million secondary transaction, delivering liquidity solutions for co-investors.
• Anchorage Capital Partners continuation vehicle investment 
  $135 million co-lead investment into a continuation vehicle organised by Anchorage Capital Partners, delivering liquidity and portfolio flexibility.

Five Arrows Secondary Investments

• Sagard Continuation Funds structuring
  €250 million continuation funds, ensuring seamless asset transition and investor alignment.
• LEA Continuation Fund formation 
  €650 million formation of a continuation fund, supporting long-term growth strategies.
• EMZ Partners Labelys and Vulcain Engineering continuation vehicle commitment 
  €80 million commitment to a continuation vehicle managed by EMZ Partners, supporting strategic investment in French industrial and engineering firms.
• Eurazeo I-TRACING Continuation Vehicle
  Advised TPG and Five Arrows as co-lead investors on their respective commitments to a €180 million single asset continuation vehicle managed by Eurazeo to support the growth of iTracing.
  
  

Other

• Astorg Syclef Continuation Fund
  Advised Astorg on its role as co-lead investor on the €530 million continuation fund, enabling the retention and further development of Syclef.
• Hayfin Implio Orphan Drugs AB 
  €650 million secondary sale, facilitating liquidity and continued investment in the life sciences sector.
• Apheon TMC HDC Long Term Value Fund formation
  €435 million formation of a long-term value fund, enabling sustained investment in technology and healthcare.
• TPG Citadel Continuation Fund SLP structuring
  €180 million continuation fund, facilitating ongoing management of core assets.
• Hayfin Investcorp Technology HWG CV-Lux secondary investment 
  €240 million secondary investment, advancing strategic objectives in the technology sector.
• L Capital Partners FineLine CV LP secondary transaction 
  $155 million secondary transaction, providing legal expertise to streamline fund operations.
• TPG Eurazeo Citadel Continuation Vehicle commitment 
  €77 million commitment to a continuation vehicle managed by Eurazeo, enabling ongoing participation in core investments.
   

• Tesco Pension Trustees Limited (trustee of the Tesco PLC Pension Scheme) 
  Sale of a portfolio of 47 limited partnership interests worth c. $1 billion to six buyer groups.
• ICG 
  Acquisition of c.170 partnership interests across multiple jurisdictions from seven fund-of-funds sellers with a value of €380 million.
• Phillipos
  Advised the Swiss family office on their series of portfolio disposals.
• Unigestion
  SH has a 17-year relationship with Unigestion as a trusted advisor for the whole group. Advised on over 250+ secondaries transactions, including over 20 portfolio disposals.